Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $19.91 Analyst target: $36.08 Upside: 81.22%
Enovis Corporation is a global medical technology company. The company is headquartered in Wilmington, Delaware.
See the full interactive analysis & chart →Informational only — not investment advice.